Topotecan hydrochloride (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Topotecan hydrochloride drug offered from Actavis Pharma, Inc.. This Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
NON-PROPRIETARY NAME: | Topotecan hydrochloride |
SUBSTANCE NAME: | TOPOTECAN HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-01-05 |
END MARKETING DATE: | 0000-00-00 |
Topotecan hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Topotecan hydrochloride from Actavis Pharma, Inc. |
LABELER NAME: | Actavis Pharma, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 4(mg/4mL) |
START MARKETING DATE: | 2015-01-05 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 45963-615_8c7f05e6-ffbb-47b4-89dd-0e881e79a8db |
PRODUCT NDC: | 45963-615 |
APPLICATION NUMBER: | ANDA090620 |
Other TOPOTECAN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: